Skip to main content
Premium Trial:

Request an Annual Quote

Commonwealth Bio Closes Genetic Testing Sale

NEW YORK (GenomeWeb News) – Commonwealth Biotechnologies said today that it has closed the sale of its bioanalytical and genetic testing businesses, and that it plans to continue its planned purchase of Shanghai-based peptide manufacturer GL Biochem.

CBI said it sold its testing businesses, CBI Services and Fairfax Identity Laboratory, to Bostwick Laboratories, a pathology lab company based in Richmond, Va., for a cash consideration and a five-year commitment to an ongoing property lease.

“The sale of these business units satisfies a key condition precedent in CBI’s acquisition of GL Biochem,” CBI’s COO, Richard Freer said in a statement.

The aim of the GL Biochem acquisition, which CBI agreed to in June, is to become an international player in the pre-clinical peptide synthesis market.

Company Director Paul D’Sylva said that the agreement would help the firm strengthen its balance sheet, cut losses, provide new fees and up-front cash, and enable the firm to retain certain land and building assets.

D’Sylva said that the deal leaves CBI “ideally positioned” to close the GL Biochem deal.

Financial terms of the agreement were not released.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.